Lv51
1510 积分 2022-06-14 加入
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
1小时前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
p53 at the crossroads of tumor immunity
3个月前
已完结
MDM2 inhibitors in sarcomas: results and next steps
5个月前
已完结
Clear cell mesotheliomas with inactivating VHL mutations and near‐haploid genomic features
6个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
6个月前
已完结
皖公网安备34019202002308
